CAS: 920113-03-7 - P 276-00
Formula:C21H20ClNO5.ClH
InChI:InChI=1S/C21H20ClNO5.ClH/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22;/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3;1H/t12-,14+;/m1./s1
InChI key:InChIKey=OOVTUOCTLAERQD-OJMBIDBESA-N
SMILES:Cl.O=C1C=C(OC=2C1=C(O)C=C(O)C2C3CCN(C)C3CO)C=4C=CC=CC4Cl
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | P276 REF: AN-AG00GVZKCAS: 920113-03-7 | 98% | To inquire | Mon 17 Jun 24 |
 | Riviciclib hydrochloride REF: TM-T6924CAS: 920113-03-7 | 99.36% | 72.00 €~616.00 € | Tue 18 Jun 24 |
 | P276-00-d4 REF: TR-P122482CAS: 920113-03-7 | - - - | 20,214.00 € | Fri 26 Jul 24 |
 | P276-00 REF: 3D-VLB11303CAS: 920113-03-7 | Min. 95% | To inquire | Mon 29 Jul 24 |
Ref: AN-AG00GVZK
| 1mg | 180.00 € | ||
| 5mg | 323.00 € | ||
| 10mg | 520.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024
Riviciclib hydrochloride
CAS:920113-03-7
Riviciclib hydrochloride (P276-00) is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 …
Formula:
C21H20ClNO5·HCl
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
438.3
Ref: TM-T6924
| 1mg | 72.00 € | ||
| 2mg | 94.00 € | ||
| 5mg | 145.00 € | ||
| 10mg | 231.00 € | ||
| 25mg | 421.00 € | ||
| 50mg | 616.00 € | ||
| 1ml*10 (DMSO) | 150.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
P276-00-d4
Controlled ProductCAS:920113-03-7
Formula:
C21H16D4ClNO5
Color and Shape:
Neat
Molecular weight:
372.544
Ref: TR-P122482
| 75mg | 20,214.00 € |
Estimated delivery in United States, on Friday 26 Jul 2024
P276-00
CAS:920113-03-7
P276-00 is an inhibitor of the MCL-1 protein, which is a pro-apoptotic protein. It has …
Formula:
C21H21Cl2NO5
Purity:
Min. 95%
Molecular weight:
438.3 g/mol
Ref: 3D-VLB11303
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 29 Jul 2024
